JENNIFER WOOD: Open Payments
NPI 1245777374 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: REXULTI, Auvelity, TRINTELLIX, INVEGA, AUSTEDO XR, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
